Fully Closed Loop Insulin Pump for Type 2 Diabetes
Part of Hormones & metabolism clinical trials.
This study tests a new automated insulin pump system (Omnipod) that adjusts insulin doses on its own throughout the day for people with type 2 diabetes. The goal is to see if it helps keep blood sugar levels more stable while reducing the burden of manual insulin management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–75 years old
- You have had type 2 diabetes for at least 6 months and have been taking insulin for at least 3 months
- You have not used an automated insulin pump in the past 3 months
- Your blood sugar control (A1C) falls within a specific range based on your current insulin type
- You can commit to wearing the pump continuously for 26 weeks and using only study-approved insulins and glucose sensors
- You do not have severe recent low blood sugar episodes (more than one in the past 6 months) or serious medical conditions that would make pump use unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two versions of the Omnipod insulin pump system to see if the newer Omnipod 6 works better at managing blood sugar than the current Omnipod 5. You'll wear one of these systems for several months and share data about how well it helps control your diabetes.
This trial tests whether a closed-loop insulin pump combined with education can help people with type 1 diabetes better recognize and avoid dangerously low blood sugar. It may be a good fit if you've had diabetes for a long time and have trouble sensing when your blood sugar drops.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This trial compares your current insulin pump therapy with a fully automated closed-loop system (artificial pancreas) that adjusts insulin using a smartphone algorithm. It aims to see which method works better for managing blood sugar levels in people with type 2 diabetes.
This trial tests a 'closed-loop' system that automatically adjusts insulin delivery for people with type 2 diabetes. If you already use insulin and certain diabetes medications, this study could help see if a smart insulin pump improves blood sugar control.
This study follows people with type 1 diabetes who are using the Omnipod 5 insulin pump. The goal is to understand how well the system works in everyday life by collecting data from your pump, continuous glucose monitor, and occasional home blood tests over one year.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.